Literature DB >> 3455681

Effects of the antiestrogens tamoxifen and clomiphene on bone resorption in vitro.

P J Stewart, P H Stern.   

Abstract

The in vitro effect of the nonsteroidal antiestrogens tamoxifen (TAM) and clomiphene (CLO) on bone resorption was investigated. TAM (100 microM) and CLO (100 microM) completely blocked PTH (2 nM)-induced resorption; 10 microM TAM was ineffective in blocking resorption, while 40-50 microM partially inhibited the response. TAM (100 microM) also completely blocked prostaglandin E2 (30 nM)- and 1,25-dihydroxy vitamin D3 (0.5 nM)-induced bone resorption. A 16-h pretreatment with TAM blocked subsequent stimulation of resorption by PTH, whereas 3.5- or 7-h pretreatment with antiestrogen was ineffective in blocking the response. Both protein and DNA syntheses were inhibited by continuous treatment (48 h) with the antiestrogens. When antiestrogen-pretreated (16 h) bones were transferred to fresh medium not containing antiestrogen, protein and DNA syntheses recovered to approximately half the control (nonantiestrogen-treated) values within 48 h. Bone resorption, however, was still completely inhibited even though macromolecular synthesis had substantially recovered. Thus, mechanisms other than macromolecular synthesis inhibition could be involved in the inhibition of bone resorption by the nonsteroidal antiestrogens TAM and CLO.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3455681     DOI: 10.1210/endo-118-1-125

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer.

Authors:  Jamal Zidan; Zohar Keidar; Walid Basher; Ora Israel
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

Review 2.  Management of menopause when estrogen cannot be used.

Authors:  R L Young; N S Kumar; J W Goldzieher
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

3.  Apparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: preliminary study.

Authors:  W G Ryan; J Wolter; J D Bagdade
Journal:  Osteoporos Int       Date:  1991-10       Impact factor: 4.507

4.  The effects of tamoxifen on the osteopenia induced by sciatic neurotomy in the rat: a histomorphometric study.

Authors:  G K Wakley; B L Baum; K S Hannon; R T Turner
Journal:  Calcif Tissue Int       Date:  1988-12       Impact factor: 4.333

5.  Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.

Authors:  H Michael; P L Härkönen; L Kangas; H K Väänänen; T A Hentunen
Journal:  Br J Pharmacol       Date:  2007-04-10       Impact factor: 8.739

Review 6.  A risk-benefit assessment of tamoxifen therapy.

Authors:  W H Catherino; V C Jordan
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

7.  The effects of a novel hormonal breast cancer therapy, endoxifen, on the mouse skeleton.

Authors:  Anne Gingery; Malayannan Subramaniam; Kevin S Pitel; Jordan M Reese; Muzaffer Cicek; Laurence B Lindenmaier; James N Ingle; Matthew P Goetz; Russell T Turner; Urszula T Iwaniec; Thomas C Spelsberg; John R Hawse
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.